Sarpogrelate Hydrochloride Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20213701
Indications:
To improve ischemic symptoms such as ulcers, pain, and cold sensation caused by chronic arterial occlusion.
Administration:
Usually, adults take 3 times daily, 100mg each time, orally after meals. However, the dosage should be adjusted appropriately according to age and symptoms.
Specifications:
100mg
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Mobile Version QR Code
Whatsapp Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.